(Q53476801)

14 May 2018

title

Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia. (English)

1 reference

14 May 2018

0 references

1 reference

Matthew S Kaufman

1

1 reference

14 May 2018

Angelica Caramanica

2

1 reference

14 May 2018

Dale Janson

3

1 reference

14 May 2018

Nancy Driscoll

4

1 reference

14 May 2018

Christina Johnson

5

1 reference

14 May 2018

Nina Kohn

6

1 reference

14 May 2018

Tarun Wasil

7

1 reference

14 May 2018

Kanti R Rai

8

1 reference

14 May 2018

publication date

17 March 2010

1 reference

14 May 2018

published in

Medical Oncology

1 reference

14 May 2018

volume

28

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

532-538

1 reference

14 May 2018

Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9478-3

Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9478-3

Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9478-3

Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9478-3

The effect of treatment with Campath-1H in patients with autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9478-3

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20237867

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-010-9478-3

1 reference

14 May 2018

1 reference

14 May 2018